Return to News

COSMIC News

COSMIC Release v94 is live!

28 May 2021

Head over to our release notes to find a detailed description of the content of this release, including a summary written by our expert curators for the genes in focus.

release v94 stats

Summary of our updates for v94

  • We have created cancer hallmark annotations for each of the 9 Cancer Gene Census Tier 1 genes (GATA1, COL2A1, CEBPA, CDKN2C, PTPN11, PTPRB, FOXL2, ACVR2A, ARHGAP26). By doing so, we are adding functional annotations for 9 genes causally associated with cancer which provide an overview of how the genes contribute to tumour development, in regard to the hallmarks of cancer.

  • Data for drug resistance is updated.

  • We are providing clarification on the changes to our terms of usage, for more details please check our licensing page.

  • For internal non-commercial usage of COSMIC - Core COSMIC website and downloads will always be free!

  • The registration for new commercial users on the COSMIC platform will only be available by contacting our Sales Partner, Qiagen, at bioinformaticssales@qiagen.com. Also, all the download files for commercial usage will only be accessible through Qiagen.

  • If you are a non-commercial user, please ensure you are registered with COSMIC and your account is verified and active. If you want to use COSMIC for commercial purposes, please contact our Sales Partner, Qiagen, at bioinformaticssales@qiagen.com to register your account.

  • We have changed our terms to clarify non-commercial and commercial usage of COSMIC. Please make sure you read and understand the changes on our licensing page.

  • Changes to our commercially-focussed download products, Actionability and CMC are available from Qiagen. Again, for licensing enquiries contact Qiagen at bioinformaticssales@qiagen.com.

Our taster files are available to access now, located on the bottom of our Licensing page.

Read more in our release notes.

Actionability

Actionability data has been fully updated. Many new trials have been added, the number of trials with results available has substantially increased, several new mutations are represented and a new gene, BTK, has been fully curated.

KEY ACTIONABILITY STATS - v94, May 2021.jpg

We have listened to the user feedback and have made changes to the Actionability download file, it includes a new Classification Id column (COSO) to link to our existing classification file. This will help to find complete disease classification in COSMIC, along with the NCIT code.

For more information about Actionability, please visit the site Actionability data.

If you have any suggestions for content or functionality that you would like to see in a coming release, please contact us at cosmic@sanger.ac.uk.

About

COSMIC, the Catalogue Of Somatic Mutations In Cancer, is the most comprehensive resource for exploring the impact of somatic mutations in human cancer. Here on our news page we aim to give you an insight into what we are doing and why. We will keep you updated with new developments and release information as well as any events we are hosting.

Tags

release

workshop

website

curation

COSMIC-3D

vacancies

downloads

user experience

data submission

website update

Cancer Gene Census

mutation ID

Hallmarks of Cancer

GRCh37

drug resistance

GRCh38

video

tutorial

birthday

International Women's Day

literature

mutational signatures

Mesothelioma

conference

AACR

gene

Bile duct cancer

cholangiocarcinoma

Europe PMC

Service announcement

blog

survey

updates

v90

search

cosv

updated

CDS

Fasta

cDNA

disease focus

world cancer day

new product

cmc

DIAS

Actionability

COSMIC

webinar

introduction to cosmic

mutations

celebrating success

Oncology

oncology trials

precision medicine

clinical trials

precision oncology

cancer

genomics

immuno oncology

breast cancer

cosmic v95

bioinformatics

cancermutationcensus

COSMICv95

Lung Cancer

Glioblastoma

testicular cancer

cancer prevention

biomarkers

Cancer Research

tumour microenvironment

copy number variants

ageing

genes

genome

clones

smoking

Clonal haematopoesis

tumour

inherited

disease

individuals

risk

variants

leukaemia

Myelodysplastic syndrome

lymphoma

haematological cancers

Myeoloproliferative neoplasms

myeloma

haematological

somatic mutations

blood cancers

blood cancer

NRAS

acral lentiginous melanoma

BRAF

melanoma

driver gene

skin cancer

uv light

Mexico

chromosome

acral melanoma

breed predisposition

genetics

PIK3CA

driver genes

canine cancer

data ecosystem

database

canine

tumour board

barrett's oesophagus

oesophageal cancer

upper gi

gene panel

cell lines project

Wellcome Sanger Institute

sanger

uv radiation

uv nail lamp

SBS18

reactive oxygen species

DNA damage

uv damage

sebaceous gland carcinoma

Kaposi cell carcinoma

Lynch syndorme

carcinoma

cancerresearch

Merkel cell carcinoma

Muir-torres syndrome

MLH1

sanger institute

Mike Stratton

cancer genome project

BRCA2

mutographs

resistance mutations